These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12654968)

  • 21. Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer.
    Tsukino H; Kuroda Y; Nakao H; Imai H; Inatomi H; Osada Y; Katoh T
    J Cancer Res Clin Oncol; 2004 Feb; 130(2):99-106. PubMed ID: 14648207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease.
    Chen M; Xia B; Chen B; Guo Q; Li J; Ye M; Hu Z
    Can J Gastroenterol; 2007 Mar; 21(3):155-8. PubMed ID: 17377643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between bone loss in periodontal disease and polymorphism of N-acetyltransferase (NAT2).
    Kocher T; Sawaf H; Fanghänel J; Timm R; Meisel P
    J Clin Periodontol; 2002 Jan; 29(1):21-7. PubMed ID: 11846845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NAT2 slow acetylator genotype as an important modifier of breast cancer risk.
    Sillanpää P; Hirvonen A; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Mitrunen K
    Int J Cancer; 2005 Apr; 114(4):579-84. PubMed ID: 15609332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
    Gu J; Liang D; Wang Y; Lu C; Wu X
    Mutat Res; 2005 Mar; 581(1-2):97-104. PubMed ID: 15725609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients.
    Borlak J; Reamon-Buettner SM
    BMC Med Genet; 2006 Jul; 7():58. PubMed ID: 16827944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-acetyltransferase-2 genotypes among patients with rheumatoid arthritis attending Jordan University Hospital.
    Oqal MK; Mustafa KN; Irshaid YM
    Genet Test Mol Biomarkers; 2012 Sep; 16(9):1007-10. PubMed ID: 22731637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-acetyltransferase 2 polymorphism and breast cancer risk with smoking: a case control study in Japanese women.
    Hara A; Taira N; Mizoo T; Nishiyama K; Nogami T; Iwamoto T; Motoki T; Shien T; Matsuoka J; Doihara H; Ishihara S; Kawai H; Kawasaki K; Ishibe Y; Ogasawara Y; Miyoshi S
    Breast Cancer; 2017 Mar; 24(2):254-262. PubMed ID: 27068825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.
    Bakayev VV; Mohammadi F; Bahadori M; Sheikholslami M; Javeri A; Masjedi MR; Velayati AA
    Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes.
    Doll MA; Zang Y; Moeller T; Hein DW
    J Pharmacol Exp Ther; 2010 Aug; 334(2):540-4. PubMed ID: 20430842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of NAT2 gene polymorphism in aetiology of the most frequent neurodegenerative diseases with dementia.
    Gołab-Janowska M; Honczarenko K; Gawrońska-Szklarz B; Potemkowski A
    Neurol Neurochir Pol; 2007; 41(5):388-94. PubMed ID: 18033638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
    Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
    Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
    Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H
    J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population.
    Quan L; Chattopadhyay K; Nelson HH; Chan KK; Xiang YB; Zhang W; Wang R; Gao YT; Yuan JM
    Oncotarget; 2016 Jun; 7(26):40012-40024. PubMed ID: 27223070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.
    Hein DW; Leff MA; Ishibe N; Sinha R; Frazier HA; Doll MA; Xiao GH; Weinrich MC; Caporaso NE
    Environ Mol Mutagen; 2002; 40(3):161-7. PubMed ID: 12355549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.
    Taylor JA; Umbach DM; Stephens E; Castranio T; Paulson D; Robertson C; Mohler JL; Bell DA
    Cancer Res; 1998 Aug; 58(16):3603-10. PubMed ID: 9721868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences.
    Golka K; Prior V; Blaszkewicz M; Bolt HM
    Toxicol Lett; 2002 Mar; 128(1-3):229-41. PubMed ID: 11869833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NAT2 slow acetylator genotype is associated with increased risk of lung cancer among non-smoking Chinese women in Singapore.
    Seow A; Zhao B; Poh WT; Teh M; Eng P; Wang YT; Tan WC; Lee EJ; Lee HP
    Carcinogenesis; 1999 Sep; 20(9):1877-81. PubMed ID: 10469638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphism of N-acetyltransferase 2 gene and the susceptibility to alcoholic liver cirrhosis: interaction with smoking.
    Yang KC; Huang YS; Perng CL; Lin HC; Lee SD
    Alcohol Clin Exp Res; 2011 Jul; 35(7):1204-8. PubMed ID: 21352246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.